Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Colinz Laboratories Ltd ("Target ....
M&A
● No Immediate Change
LOW RISK
📅 Filed on BSE: 31 Jul 2026, 06:03 PM IST · BSE ID: bc51b0d9-6e39-440b-bda5-8794528622f3
View Original BSE Filing (PDF)
💡
In Simple Terms
An open offer letter has been submitted for shareholders of Colinz Laboratories to acquire 26% of the company at ₹54 per share.
🤖 AI Summary
- Saffron Capital Advisors submitted the Letter of Offer for the open offer in Colinz Laboratories Ltd.
- Acquirers Annjana Dugar, Likhitta Dugar, and Antariksh Dugar, with PAC Padam Dugar, are making the offer.
- The open offer is to acquire up to 6,54,966 fully paid-up Equity Shares of Colinz Laboratories Ltd.
- The offer price is ₹ 54/- per Equity Share, aggregating up to ₹ 3,53,68,164/-.
- This represents 26% of the Voting Share Capital of Colinz Laboratories Ltd.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Equity Shares to be Acquired
6,54,966
Offer Price per Equity Share
₹ 54/-
Aggregate Value of Open Offer
₹ 3,53,68,164/-
Percentage of Voting Share Capital
26%
🏢 How This Affects the Company
The completion of the open offer will result in a change in control of Colinz Laboratories Limited, as stated in the SEBI (SAST) Regulations, 2011.
👥 What This Means For Shareholders
✅
Action Required
Public shareholders of Colinz Laboratories Limited who wish to participate in the open offer should refer to the Letter of Offer for instructions on tendering their shares.
👤
Who Is Affected
Public shareholders of Colinz Laboratories Limited are eligible to participate in the open offer to sell up to 6,54,966 shares at ₹ 54/- per share.
🔍
Management Signal
The submission of the Letter of Offer indicates the acquirers' intent to proceed with the acquisition and comply with SEBI (SAST) Regulations, 2011.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Open offer tendering period details and dates for public shareholders.
Outcome of the open offer and final shareholding changes.
Any post-offer announcements regarding management or board changes.
LOW RISK
The filing is a procedural update for an ongoing open offer, with no immediate new risks indicated.
💡 Investor Takeaway
The Letter of Offer for the open offer by Annjana Dugar, Likhitta Dugar, and Antariksh Dugar, along with PAC Padam Dugar, to acquire 6,54,966 equity shares of Colinz Laboratories Ltd. at ₹ 54/- per share, totaling ₹ 3,53,68,164/-, has been submitted.
📅 Company Track Record
A previous filing on 2026-07-04 announced the open offer for 26% of Colinz Laboratories Ltd at ₹54 per share, with a total value of ₹3,53,68,164/-.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the purpose of this filing by Colinz Laboratories Ltd?
The filing announces the submission of the Letter of Offer by Saffron Capital Advisors for the open offer to acquire shares of Colinz Laboratories Ltd. by Annjana Dugar, Likhitta Dugar, and Antariksh Dugar.
How many shares are the acquirers proposing to acquire in Colinz Laboratories Ltd?
The acquirers are proposing to acquire up to 6,54,966 fully paid-up Equity Shares of Colinz Laboratories Limited.
What is the offer price per share for the open offer for Colinz Laboratories Ltd?
The offer price is ₹ 54/- (Rupees Fifty Four only) per Equity Share.
What is the total value of the open offer for Colinz Laboratories Ltd?
The total value of the open offer aggregates up to ₹ 3,53,68,164/- (Rupees Three Crore Fifty Three Lakh Sixty Eight Thousand One Hundred Sixty Four Only).
What percentage of Colinz Laboratories Ltd.'s voting share capital does this open offer represent?
The open offer represents 26% (Twenty Six Percent) of the Voting Share Capital of Colinz Laboratories Limited.
Questions based on this BSE filing only. For information purposes.